Commentary: Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis
Saved in:
| Main Authors: | Tao Wang, Xuan Zhang, Guo-Ming Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-09-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1417921/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The epigenetic role of EZH2 in acute myeloid leukemia
by: Jinyong Fang, et al.
Published: (2024-12-01) -
Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential
by: Maria Saveria Gilardini Montani, et al.
Published: (2024-12-01) -
EZH2 specifically regulates ISL1 during embryonic urinary tract formation
by: Enrico Mingardo, et al.
Published: (2024-10-01) -
Immunoexpressions of PD-L1 and EZH2 in Endometrial Carcinoma: Associations with Clinicopathological Parameters
by: Badrul Iskandar Abdul Wahab, et al.
Published: (2025-04-01) -
ROS regulates circadian rhythms by modulating Ezh2 interactions with clock proteins
by: Hao-yi Zhang, et al.
Published: (2025-04-01)